VRNA Verona Pharma plc American Depositary
3,353
$14.85
$0.10
(0.68%)
| Watchers | 3,353 |
| 52-Wk Low | $11.83 |
| 52-Wk High | $23.07 |
| Market Cap | $1.14B |
| Volume | 762,317.00 |
| 52-Wk High | $23.07 |
| 52-Wk Low | $11.83 |
17,800 Shares in Verona Pharma plc (NASDAQ:VRNA) Purchased by PFG Investments LLCZolmax • about 1 month ago
PFG Investments LLC bought a new stake in Verona Pharma plc (NASDAQ:VRNA Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The...
Share to Feed
Verona Pharma plc (NASDAQ:VRNA Get Free Report) shares fell 7.6% during mid-day trading on Thursday . The company traded as low as $15.42 and last traded at $15.42. 80,327 shares changed...
This is a Bearish indicator signaling VRNA's price could decline from here. Traders may explore shorting the stock or put options...
This indicator may be signaling that VRNA's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
HC Wainwright restated their buy rating on shares of Verona Pharma (NASDAQ:VRNA Free Report) in a report published on Monday morning, Benzinga reports. They currently have a $32.00 target...
This is a signal that VRNA's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...
This indicator may be signaling that VRNA's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
This price move could indicate a change in the trend, and may be a sell signal for investors...
Verona Pharma (VRNA Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Ram Selvaraju from H.C...
LONDON and RALEIGH, N.C., March 04, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) ( Verona Pharma or the Company ), announces Mr. Andrew Fisher has today joined the Company as General...